BioGen's RSV vaccine faces 2026 Phase III trials. Learn why 30,000+ participants and FDA mandates shape its path to efficacy.
·
·
7 min read
How are global health partnerships speeding up vaccine development and access? Learn 3 key ways, like CEPI's open-access platform.
·
·
7 min read
Why People First 2026 needs empathy. Learn how continuous learning & AI augmentation keep top talent, reducing external hiring costs by 15%.
·
·
7 min read
WHO vaccine trials for diseases like Lassa fever offer global hope. Learn how new vaccines reduce disease by 30% in crisis zones.
·
·
6 min read
Finance struggles to attract young talent. Learn why the industry has an image problem, and 5 ways it can engage Gen Z by 2027.
·
·
7 min read
Craft alcohol sales grew 15% in 2025, challenging big brands. See how consumer demand for unique drinks impacts your favorite beverages.
·
·
5 min read
We're $10B short annually for pandemic prep. See why global health security is weak, with only 33% of countries ready for outbreaks.
·
·
6 min read
Can advanced therapies reach everyone? See how decentralized trials & ICH E19 aim for broader access by 2027, impacting global health equity.
·
·
8 min read
2026 sees new media focus on business leaders. Learn why this scrutiny matters for corporate reputation and stock prices.
·
·
9 min read
Investment is shifting from humanoid robots to specialized AI. Why is $100B+ going to AI annually, and what does it mean for your business?
·
·
7 min read